Meeting
2013 ASCO Annual Meeting
Alteration of the p53 and Rb tumor suppressor pathways by p16/INK4a and p14/ARF promoter methylation and loss of protein expression in recurrent and nonrecurrent meningiomas.
Authors
Juan Carlos Martinez
Instituto Oftalmico/Hospital Universitario Gregorio Marañon, Madrid, Spain
Juan Carlos Martinez , Santiago Ropero , Concepcion Mateos , Maria DEL VAL Toledo , Rafael Samaniego , Silvia Sacristan , Manel Esteller
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 31, 2013 (suppl; abstr 2064)
DOI
10.1200/jco.2013.31.15_suppl.2064
Abstract #
2064
Poster Bd #
4D
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Microbiome signature, global methylation and immune landscape in early onset colorectal cancer.
First Author: Ning Jin
Poster
2024 ASCO Annual Meeting
Prediction of recurrence in stage I EGFR mutation-positive NSCLC: Combination of CT appearance and selected co-occurring gene alterations by machine learning.
First Author: Akiko Tateishi
Poster
2024 ASCO Annual Meeting
Clinical outcomes of NOTCH pathway-activated adenoid cystic carcinoma with and without co-occurrent TP53 mutation.
First Author: Syeda Malaika Haider
Poster
2024 ASCO Annual Meeting
Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer.
First Author: Bonnita Werner